Identification of potential salivary biomarker panels for oral squamous cell carcinoma A Jain, CN Kotimoole, S Ghoshal, J Bakshi, A Chatterjee, TSK Prasad, ... Scientific Reports 11 (1), 1-14, 2021 | 27 | 2021 |
Cripto 1, a potential biomarker for oral squamous cell carcinoma A Jain, S Mallupattu, R Thakur, S Ghoshal, A Pal Oral oncology 90, 153-154, 2019 | 10 | 2019 |
TIMP‐2 as a noninvasive urinary marker for predicting neurogenic bladder in patients under follow‐up for spina bifida RS Shubhalaxmi Nayak, Monika Bawa, Ravi P. Kanojia, Arnab Pal, Anu Jain Neurourology and urodynamics, 2020 | 4* | 2020 |
Urinary Proteomics for Discovery of Gastric Cancer Biomarkers to Enable Precision Clinical Oncology N Joshi, F Bhat, A Bellad, G Sathe, A Jain, S Chavan, R Sirdeshmukh, ... OMICS: A Journal of Integrative Biology 27 (8), 361-371, 2023 | 2 | 2023 |
Role of oncofetal protein CR-1 as a potential tumor marker for oral squamous cell carcinoma A Jain, SK Mallupattu, R Thakur, S Mohindra, A Bal, A Das, S Ghoshal, ... Indian Journal of Clinical Biochemistry, 1-8, 2020 | 2 | 2020 |
Testican 1 (SPOCK1) and protein tyrosine phosphatase, receptor type S (PTPRS) show significant increase in saliva of tobacco users with oral cancer V Nanjappa, R Raja, A Radhakrishnan, AP Jain, KK Datta, ... Translational Research in Oral Oncology 3, 2057178X18800534, 2018 | 2 | 2018 |
Defining albumin as a glycoprotein with multiple N-linked glycosylation sites K Garapati, A Jain, BJ Madden, DG Mun, J Sharma, R Budhraja, ... Journal of Translational Medicine 22 (1), 454, 2024 | 1 | 2024 |
Liposome-encapsulated mannose-1-phosphate therapy improves global N-glycosylation in different congenital disorders of glycosylation R Budhraja, S Radenkovic, A Jain, IJJ Muffels, MHA Ismaili, T Kozicz, ... Molecular Genetics and Metabolism, 108487, 2024 | 1 | 2024 |
Data‐Independent Acquisition and Label‐Free Quantification for Quantitative Proteomics Analysis of Human Cerebrospinal Fluid KAT Makepeace, AW Rookyard, L Das, BN Vardarajan, JK Chakrabarty, ... Current Protocols 4 (3), e1014, 2024 | 1 | 2024 |
A proteomic analysis identifies higher AHSG (alpha-2-HS-glycoprotein) in saliva of oropharyngeal cancer patients–a potential salivary biomarker. A Jain, AA Khan, R Kaur, R Verma, J Bakshi, A Chatterjee, A Bal, ... Oral Oncology Reports, 100478, 2024 | | 2024 |
A complement C4–derived glycopeptide is a biomarker for PMM2-CDG K Garapati, R Budhraja, M Saraswat, J Kim, N Joshi, GS Sachdeva, A Jain, ... JCI insight 9 (7), 2024 | | 2024 |
Exploration of nitrotyrosine-containing proteins and peptides by antibody-based enrichment strategies FA Bhat, KK Mangalaparthi, H Ding, A Jain, JS Hsu, JA Peterson, ... Molecular & Cellular Proteomics, 100733, 2024 | | 2024 |
Letter to Editor" The Role of Nodal and Cripto-1 in Human Oral Squamous Cell Carcinoma". A Jain, S Ghoshal, A Pal Oral Diseases, 2020 | | 2020 |
Development of a potential salivary biomarker panel for Oral Squamous Cell Carcinoma. A Jain, CN Kotimoole, S Ghoshal, J Bakshi, A Chatterjee, TSK Prasad, ... medRxiv, 2020 | | 2020 |
Oncofetal Protein Cripto-1 in a new clinical role: a potential tumor marker for Oral Squamous Cell Carcinoma. A Jain, SK Mallupattu, R Thakur, S Mohindra, A Bal, A Das, S Ghoshal, ... medRxiv, 19000950, 2019 | | 2019 |
35P Clinical significance of expression of cripto-1 in patients of squamous cell carcinoma of oropharynx MS Kumar, A Pal, A Jain, S Ghoshal, B Rai, S Mohindra, A Das Annals of Oncology 27, ix10-ix11, 2016 | | 2016 |
CRIPTO-1: A NOVEL TUMOR MARKER FOR ORAL SQUMOUS CELL CARCINOMA (OSCC): M256 A Jain, A Pal, R Thakur, S Ghoshal, MS Kumar, S Mohindra Clinical Chemistry and Laboratory Medicine 53, 2015 | | 2015 |